ID   BP455
AC   CVCL_B4UE
DR   PRIDE; PXD012308
DR   Wikidata; Q110432639
RX   PubMed=31611696;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   HLA typing: A*02:01,31:01; B*39:06,40:01; C*03:04,07:02 (Direct_author_submission).
CC   HLA typing: DPA1*01:03; DPB1*02:01; DQA1*01:05,01:10; DQB1*05:01,06:03; DRB1*10:01,13:01; DRB3*01:01 (PubMed=31611696).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: HLA class II peptidome analysis by proteomics.
CC   Miscellaneous: HLA class I typing from personal communication of Bassani-Sternberg, Michal.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-09-24; Version: 6
//
RX   PubMed=31611696; DOI=10.1038/s41587-019-0289-6;
RA   Racle J., Michaux J., Rockinger G.A., Arnaud M., Bobisse S., Chong C.,
RA   Guillaume P., Coukos G., Harari A., Jandus C., Bassani-Sternberg M.,
RA   Gfeller D.;
RT   "Robust prediction of HLA class II epitopes by deep motif
RT   deconvolution of immunopeptidomes.";
RL   Nat. Biotechnol. 37:1283-1286(2019).
//